A protest over a draft decision not to recommend a new cystic fibrosis drug is due later. Campaigners keen to see Kalydeco introduced across Wales are aiming to make their voices heard outside a meeting of the All Wales Medicines Strategy Group at the Angel Hotel in Abergavenny.
The group will look at the recommendation and decide whether to approve it or not. The drug - which is already available in England, Scotland and Northern Ireland - is the first licensed drug that treats the G551D mutation - the fundamental defect in those with cystic fibrosis.
More top news
Rain and drizzle will clear eastern counties this evening. Remaining mild with breaks in the cloud by dawn.
A leading vet charity warns that you could end up with a stressed, lonely or even aggressive pet if you don't care for it properly.
From pensioners to first-time buyers to public sector workers, a rundown of how today's Autumn Statement and Spending Review affect you.